Ignite Creation Date:
2025-12-24 @ 6:28 PM
Ignite Modification Date:
2026-02-05 @ 7:45 AM
Study NCT ID:
NCT01772368
Status:
COMPLETED
Last Update Posted:
2017-06-12
First Post:
2013-01-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Asthma | View |